welcome to oneEDSvoice
- a positively charged Ehlers Danlos Syndrome community.- join today!
- login
scientific articles
The Successful Use of Recombinant Factor VIIa in a Patient with Vascular-Type Ehlers-Danlos Syndrome
source: Acta Anaesthesiologica Scandinavica
year: 2007
authors: Faber P, Craig WL, Duncan JL, Holliday K
summary/abstract:Vascular-type Ehlers-Danlos syndrome is an inherited connective tissue disorder resulting in an increased risk of serious peri-operative bleeding during surgery for spontaneous organ or vessel rupture. The excessive bleeding may result in coagulopathy, and thus compound the difficulty in securing surgical haemostasis. With the advent of recombinant factor VIIa, a new therapy has become available for the management of intractable surgical bleeding.
organization: Aberdeen Royal InfirmaryDOI: 10.1111/j.1399-6576.2007.01416.x
read more full text source
expertly curated content related to this topic
-
New Lethal Disease Involving Yype I and III Collagen Defect Resembling Geroderma Osteodysplastica, De Barsy Syndrome...We describe the clinical findings and bi...
-
Generalized Hyperalgesia in Children and Adults Diagnosed with Hypermobility Syndrome and Ehlers-Danlos Syndrome Hyp...OBJECTIVE: Lowered pressure-pain thresh...
-
2018 Alexander technique workshopThe Ehlers-Danlos Society is excited to ...
-
Jennifer Ortiz, PT, MPT, WSCJennifer Ortiz has Graduated from Loma L...
-
Special Like Me… Ehlers-Danlos Syndrome (EDS)Uniquely designed to assist parents, car...
-
Jonah Murdock, PhD, MDJonah Murdock, M.D., Ph.D. is a board ce...
-
Neil Schechter, MDDr. Neil Schechter currently directs the...
